David Mikhail

Dr. David Mikhail

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Surgical Clinics of North America
Verified
Journal Article
Closed access
DMDavid Mikhail
David Mikhail
JSJoseph Sarcona
Joseph Sarcona
MMMina Mekhail
Mina Mekhail
LRLee Richstone
Lee Richstone

24 March 2021 in Journal of Surgical Education
Verified
Journal Article
Closed access
DMDavid Mikhail
David Mikhail
EMEzra J. Margolin
Ezra J. Margolin
JSJohn Sfakianos
John Sfakianos
MCMarisa Clifton
Marisa Clifton
MSMathew Sorenson
Mathew Sorenson
LRLee Richstone
Lee Richstone

2 April 2021 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
VBVinaya P. Bhatia
Vinaya P. Bhatia
TATareq Aro
Tareq Aro
SSShannon M. Smith
Shannon M. Smith
PSPatrick Samson
Patrick Samson
ELElizabeth Lynch
Elizabeth Lynch
DHDavid M. Hoenig
David M. Hoenig

1 February 2015 in Canadian Journal of Ophthalmology
Verified
Journal Article
Closed access
DMDavid Mikhail
David Mikhail
KVKari L. Visscher
Kari L. Visscher
NCNancy Chen
Nancy Chen
JWJoy Wang
Joy Wang
BEBarry Y. Emara
Barry Y. Emara
CHCindy M. Hutnik
Cindy M. Hutnik

1 November 2019 in The American Journal of Surgery
Verified
Journal Article
Closed access
JCJingwen Chen
Jingwen Chen
DMDavid Mikhail
David Mikhail
HSHemant Sharma
Hemant Sharma
JJJeffrey Jevnikar
Jeffrey Jevnikar
MCMatthew Cooper
Matthew Cooper
ASAlp Sener
Alp Sener

1 September 2021 in Journal of Endourology
Verified
Journal Article
Closed access
ARArun Rai
Arun Rai
TATareq Aro
Tareq Aro
ELElizabeth Lynch
Elizabeth Lynch
CTChristian Tabib
Christian Tabib
DMDavid Mikhail
David Mikhail
ZOZeph Okeke
Zeph Okeke
While percutaneous nephrolithotomy (PCNL) remains the treatment modality of choice for kidney stones larger than 2 cm, infectious complications are most common, ranging from 5% to 32%. We present here a novel technique for potentially improving collecting system sterility during PCNL and initial postoperative outcomes. Retrospective chart analysis data of our irrigation protocol were collected from our first 56 patients between February and July 2019. Traditional prone PCNL was performed in a standard manner using fluoroscopic guidance. Using a ureteral catheter that was placed cystoscopically, a renal pelvis urine culture was taken and subsequently 10 mL of betadine solution was instilled into the collecting system. Gentamicin in normal saline (80 mg/3 L) was utilized as the irrigant fluid for the first 6 L of irrigation. From this cohort, 57% patients were women and mean age was 60 ± 14 years. About 23% of patients were diabetic and 55% were hypertensive. Seventy percent of patients had stone burden >2 cm and no patients had stone burden <1 cm. Fifteen patients had positive urine cultures treated preoperatively, while four patients had contaminated cultures. All patients were treated with our antibiotic irrigation and betadine protocol regardless of preoperative cultures or antibiotics. Mean baseline creatinine level was 0.95 ± 0.41, with a mean change of 0.18 at postoperative day 1. Of the 15 (26%) of 56 patients with a systemic inflammatory response syndrome response (two of following four criteria: white blood cells 12; heart rate >90; hypothermia 100.4°F; and respiratory rate >20), only six patients (11%) were febrile and two patients had positive blood cultures (3%). There were no adverse reactions to the betadine or antibiotic irrigation. We present here our initial experience of a new technique for renal pelvis sterilization and its safety and feasibility using intrarenal instillation of betadine and antibiotic irrigation. No Clinical Trial Registration number applicable.